Texas Children's Hospital in Austin performs fetal blood transfusion to save the life of baby exposed to childhood illness.

Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program.

Gegen, 35, had been the picture of health. He has no memory of the next 10 days, but he benefited from a new approach to how ...

State auditors flagged mismanagement and political influence in AICS and AKAP, yet the bicameral committee still approved ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo Dupix ...

From a global regulatory perspective, Cytokinetics is expanding its footprint rapidly. The drug received approval in China on ...

The program, included in President Donald Trump’s “Big Beautiful Bill,” offers a generous tax incentive to people who donate to scholarship organizations.

Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly ...

Trump intends to move marijuana from a Schedule I drug, a category that includes dangerous drugs that have no accepted ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo ...

Learn how climate change is impacting Christmas tree farms in New Hampshire and Vermont, forcing farmers to adapt and innovate to survive.

Cybersecurity protection is a C-suite issue that is so fast-changing and technical, it’s hard for CEOs to properly manage.